[SRNE] YoY Quarter Result on 31-Mar-2013 [#Q1]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
15-May-2013
Financial Year
2013
Quarter
31-Mar-2013 [#Q1]
Profit Trend
QoQ- -43.70%
YoY- -178.37%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Revenue 988 977 976 134 110 235 0 -
PBT -20,027 -10,616 -10,093 -2,522 -906 -684,443 -600 79.34%
Tax -1,637 -178 4 2 3 1,644 3 -
NP -18,390 -10,438 -10,093 -2,522 -906 -684 -600 76.81%
Tax Rate - - - - - - - -
Total Cost 19,378 11,415 11,069 2,656 1,016 920 600 78.35%
Ratio Analysis
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
NP Margin -1,861.34 -1,068.37 -1,034.12 -1,881.46 -822.64 -290.80 0.00 -
Per Share
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
EPS -0.48 -0.29 -0.44 -0.20 -0.09 -0.07 -0.07 37.79%
EPS Diluted -0.48 -0.29 -0.44 -0.20 -0.09 -0.07 -0.07 37.79%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.